New drug shown safe, effective in treating hereditary angioedema

Clinical trials from two international research teams have shown that icatibant, a new drug that blocks the action of an inflammatory protein known as bradykinin, is safe and effective in treating acute attacks of hereditary angioedema, a potentially life-threatening condition.

Read the whole article on Science Daily

More from Science Daily